Bringing Advanced Therapies for Parkinson's Disease to the Clinic: The Patient's Perspective

J Parkinsons Dis. 2021;11(s2):S141-S145. doi: 10.3233/JPD-212650.

Abstract

There is an urgent unmet need in the Parkinson's disease community-advanced therapies to modify the inevitable decline that occurs in those affected by this progressive neurodegenerative disease for which there is no cure. This will require collaboration from all stakeholders and central to those partnerships are patients themselves. But participation in clinical trials and clinical use of advanced therapies have their own risk profile above and beyond standard therapeutics as evidenced by past invasive procedures. Therefore, it is of utmost importance that clear, evidence-based information about these potential treatments be clearly communicated by those exploring their use to ensure safe and informed participation from the patient community. Likewise, patients must weigh the benefits of these treatments their limitations and risks in order to truly give informed consent to participate in bringing these treatments to the clinic. Here we explore these issues from the patient perspective.

Keywords: Parkinson’s disease; advanced treatments; clinical research; gene therapy; patient risk; patient-centered; recruitment; stem cell replacement.

Publication types

  • Review

MeSH terms

  • Humans
  • Informed Consent
  • Neurodegenerative Diseases*
  • Parkinson Disease* / therapy